Last reviewed · How we verify

Ashwagandha

Sutter Health · FDA-approved active Small molecule

Ashwagandha is a Small molecule drug developed by Sutter Health. It is currently FDA-approved. Also known as: ASWD, withania somnifera.

At a glance

Generic nameAshwagandha
Also known asASWD, withania somnifera
SponsorSutter Health
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ashwagandha

What is Ashwagandha?

Ashwagandha is a Small molecule drug developed by Sutter Health.

Who makes Ashwagandha?

Ashwagandha is developed and marketed by Sutter Health (see full Sutter Health pipeline at /company/sutter-health).

Is Ashwagandha also known as anything else?

Ashwagandha is also known as ASWD, withania somnifera.

What development phase is Ashwagandha in?

Ashwagandha is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing